Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11711
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGleich, Kurten
dc.contributor.authorDesmond, Michael Jen
dc.contributor.authorLee, Darrenen
dc.contributor.authorBerkovic, Samuel Fen
dc.contributor.authorDibbens, Leanne Men
dc.contributor.authorKaterelos, Marinaen
dc.contributor.authorBayly, Marta Aen
dc.contributor.authorFraser, Scott Aen
dc.contributor.authorMartinello, Paulen
dc.contributor.authorVears, Danya Fen
dc.contributor.authorMount, Peteren
dc.contributor.authorPower, David Anthonyen
dc.date.accessioned2015-05-16T01:19:45Z
dc.date.available2015-05-16T01:19:45Z
dc.date.issued2013-02-01en
dc.identifier.citationBioresearch Open Access; 2(1): 40-6en
dc.identifier.govdoc23515316en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11711en
dc.description.abstractMutations of the intrinsic lysosomal membrane protein SCARB2 cause action myoclonus-renal failure syndrome (AMRF syndrome), a rare disease characterized by renal and neurological manifestations. In this study, examination of Cos7 cells transfected with SCARB2 cDNA derived from two patients with AMRF syndrome showed that the resultant protein was truncated and was not incorporated into vesicular structures, as occurred with full-length SCARB2 cDNA. Mutant SCARB2 protein failed to colocalize with lysosomes and was found in the endoplasmic reticulum or the cytosol indicating a loss of function. Cultured skin fibroblast and Epstein-Barr virus-transformed lymphoblastoid B cell lines (LCLs) were created from these two patients. Despite the loss of SCARB2 function, studies with lysosomal-associated membrane protein (LAMP) 1 and LAMP2 demonstrated normal lysosomal numbers in fibroblasts and LCLs. Immunofluorescence microscopy using anti-LAMP1 and anti-LAMP2 antibodies also showed normal lysosomal structures in fibroblasts. There was no change in the morphology of fibroblasts examined by electron microscopy compared with cells from unaffected individuals. By contrast, LCLs from individuals bearing SCARB2 mutations had large intracellular vesicles that resembled autophagosomes and contained heterogeneous cellular debris. Some of the autophagosomes were seen to be extruding cellular contents into the media. Furthermore, LCLs had elevated levels of microtubule-associated protein light chain 3-II, consistent with increased autophagy. These data demonstrate that SCARB2 mutations are associated with an inability to process autophagosomes in B lymphocytes, suggesting a novel function for SCARB2 in immune function.en
dc.language.isoenen
dc.subject.otherbiochemistryen
dc.subject.othercellular biologyen
dc.subject.othergeneticsen
dc.subject.otherphysiologyen
dc.titleAbnormal Processing of Autophagosomes in Transformed B Lymphocytes from SCARB2-Deficient Subjects.en
dc.typeJournal Articleen
dc.identifier.journaltitleBioResearch open accessen
dc.identifier.affiliationThe Institute for Breathing and Sleep, Austin Health , Heidelberg, Australia .en
dc.identifier.doi10.1089/biores.2012.0265en
dc.description.pages40-6en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/23515316en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.